Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of ß-catenin signaling. (2017)

First Author: Berwick DC
Attributed to:  Regulation of Wnt and calcium signalling by the Parkinson's disease protein LRRK2 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13024-017-0153-4

PubMed Identifier: 28103901

Publication URI: http://europepmc.org/abstract/MED/28103901

Type: Journal Article/Review

Volume: 12

Parent Publication: Molecular neurodegeneration

Issue: 1

ISSN: 1750-1326